Prophylactic ICDs
This article was originally published in The Gray Sheet
Executive Summary
Medtronic joins Guidant's request for Medicare coverage for prophylactic implantation of cardioverter defibrillators in patients with prior myocardial infarction and an ejection fraction of 30% or less with or without evidence of arrhythmias, CMS announces July 16. Evaluated in Guidant's MADIT II study, the broadened ICD indication was approved July 18 via PMA supplement (1"The Gray Sheet" July 22, 2002, p. 15)...
You may also be interested in...
Guidant Gains FDA Approval Of MADIT II Indication, Reports Upbeat ICD Sales
Patient electrophysiology testing "may not be required" for some patients prior to Guidant ICD implantation under an expanded indication, FDA says
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.